Interestingly, this increased expression of MYO3A was also observed in T1DM patients with hyperlipidemia and previous studies have demonstrated a correlation between abnormal lipid profile such as hypercholesterolemia and single nucleotide polymorphism in MYO3A which eventually affects the cardiac system, adversely36. The gene discussed is MYO3A; the disease is hyperlipidemia.